Understand the source comparison
Comparison: SLU-PP-332 vs Other Metabolic Research Compounds
Understanding how long SLU-PP-332 takes to work requires comparison to compounds with similar metabolic goals but different mechanisms. SLU-PP-332 ERRα agonist. Direct nuclear receptor activation 1–2 hours (transcriptional changes in mitochondrial genes) 4–6 h
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Understanding how long SLU-PP-332 takes to work requires comparison to compounds with similar metabolic goals but different mechanisms.
- SLU-PP-332
- ERRα agonist. Direct nuclear receptor activation
- 1–2 hours (transcriptional changes in mitochondrial genes)
- 4–6 hours (peak oxidative capacity and fatty acid oxidation)
- 7–14 days (mitochondrial density increase, endurance improvement)
- Fastest onset for mitochondrial effects due to direct nuclear action. Requires consistent dosing for structural adaptation.
- GW501516 (Cardarine)
- PPARδ agonist. Upregulates fatty acid oxidation genes
- 2–4 hours (initial gene transcription)
- 6–8 hours (increased fat oxidation during activity)
- 10–21 days (endurance adaptation, metabolic shift)
- Slower onset than SLU-PP-332. Works through different receptor (PPARδ vs ERRα). Longer history in performance research.
- AICAR
- AMPK activator. Mimics exercise-induced metabolic signaling
- 30–60 minutes (AMPK phosphorylation)
- 2–3 hours (glucose uptake, fatty acid oxidation)
- 5–10 days (mitochondrial biogenesis, endurance gains)
- Fastest acute metabolic activation, but less direct mitochondrial biogenesis than SLU-PP-332. Effects highly dependent on activity timing.
- SR9009 (Stenabolic)
- REV-ERB agonist. Modulates circadian metabolism and mitochondrial function
- 1–2 hours (circadian gene modulation)
- 3–4 hours (increased energy expenditure)
- 7–14 days (metabolic rhythm optimization, fat loss)
- Similar onset to SLU-PP-332 but works through circadian pathways rather than direct mitochondrial biogenesis. Short half-life requires multiple daily doses.